Evidence map›Paper›PMID 31655757›Full record

ReviewPrimary care2019

The Business Case for Population Health Management.

Jason H Wasfy, Timothy G Ferris

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Primary care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jason H WasfyCardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Massachusetts General Physicians Organization, Harvard Medical School, Boston, MA, USA. Electronic address: jwasfy@mgh.harvard.edu.
Timothy G FerrisMassachusetts General Physicians Organization, Harvard Medical School, Boston, MA, USA; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Massachusetts General Hospital · US

Funding

Harvard Clinical and Translational Science CenterKL2TR001100 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2013 to 2017
$8.5M
NCATS NIH HHS KL2 TR001100
6 · The paper itself

Abstract

American health care is shifting from a fixed-cost, fee-for-service payment model to value-based payment, in which providers including physicians and hospitals increasingly face incentives to reduce the total cost of care and meet specific quality benchmarks. Leaders of organizations that pay for health care and employers have encouraged this shift in response to substantial increases in health care costs and generally mediocre health outcomes compared with other countries. Here, we make the case that although the pace and details of such payment reforms are uncertain, these underlying structural economic challenges make a transition to some sort of value-based care inevitable.

Indexed as

Health Care CostsPopulation Health ManagementPractice ManagementAccountable Care OrganizationsFee-for-Service PlansReimbursement MechanismsSocial ValuesUnited StatesAccountable care organizationsHealth policyPopulation health management

Identifiers

PMID31655757
PMCPMC6853600
OpenAlexW2966228254

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.